Total Payments
$138,069
2024 Payments
$6,113
Companies
46
Transactions
1,143
Medicare Patients
2,239
Medicare Billing
$229,814
Payment Breakdown by Category
Other$102,275 (74.1%)
Food & Beverage$21,831 (15.8%)
Travel$13,359 (9.7%)
Education$304.73 (0.2%)
Consulting$300.00 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $81,475 | 35 | 59.0% |
| Food and Beverage | $21,831 | 1,050 | 15.8% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $20,800 | 7 | 15.1% |
| Travel and Lodging | $13,359 | 44 | 9.7% |
| Education | $304.73 | 6 | 0.2% |
| Consulting Fee | $300.00 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $88,933 | 354 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14,780 | 174 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $12,948 | 31 | $0 (2017) |
| Allergan Inc. | $7,282 | 51 | $0 (2019) |
| Synergy Pharmaceuticals Inc | $4,167 | 17 | $0 (2018) |
| Janssen Biotech, Inc. | $1,411 | 88 | $0 (2024) |
| Gilead Sciences, Inc. | $1,208 | 75 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,175 | 75 | $0 (2024) |
| PFIZER INC. | $796.60 | 42 | $0 (2024) |
| Celgene Corporation | $771.21 | 32 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,113 | 125 | ABBVIE INC. ($5,084) |
| 2023 | $21,162 | 136 | AbbVie Inc. ($19,942) |
| 2022 | $21,019 | 179 | ABBVIE INC. ($19,478) |
| 2021 | $9,161 | 110 | AbbVie Inc. ($7,625) |
| 2020 | $8,404 | 64 | AbbVie Inc. ($7,871) |
| 2019 | $7,726 | 141 | AbbVie, Inc. ($5,901) |
| 2018 | $36,564 | 202 | AbbVie, Inc. ($17,089) |
| 2017 | $27,921 | 186 | Valeant Pharmaceuticals North America LLC ($12,948) |
All Payment Transactions
1,143 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $9.80 | General |
| Category: Gastroenterology | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $27.88 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $1.60 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $1.24 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $0.40 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Gastroenterology | ||||||
| 10/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $1.61 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $0.94 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $0.80 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Rare Disease | ||||||
| 10/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $4.88 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Immunology | ||||||
| 10/14/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Immunology | ||||||
| 10/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $24.41 | General |
| Category: Neuroscience | ||||||
| 10/08/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/02/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.25 | General |
| 10/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Immunology | ||||||
| 09/30/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.94 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/24/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 437 | 761 | $221,184 | $50,707 |
| 2022 | 13 | 532 | 558 | $256,372 | $53,658 |
| 2021 | 14 | 623 | 672 | $295,039 | $69,769 |
| 2020 | 13 | 647 | 674 | $242,957 | $55,681 |
Total Patients
2,239
Total Services
2,665
Medicare Billing
$229,814
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 47 | 47 | $54,721 | $9,520 | 17.4% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 32 | 241 | $36,632 | $8,765 | 23.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 32 | 136 | $13,600 | $6,578 | 48.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 62 | $13,454 | $5,061 | 37.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 53 | 57 | $8,436 | $3,483 | 41.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $10,292 | $3,449 | 33.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 19 | 19 | $14,029 | $3,301 | 23.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 48 | 49 | $36,860 | $3,290 | 8.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 21 | 21 | $19,416 | $2,205 | 11.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 34 | 34 | $4,216 | $1,846 | 43.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 31 | 31 | $4,681 | $1,486 | 31.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $2,847 | $1,070 | 37.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 20 | 20 | $2,000 | $652.65 | 32.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 137 | 154 | $33,418 | $13,291 | 39.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 47 | 47 | $52,139 | $8,829 | 16.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 50 | 50 | $16,600 | $5,769 | 34.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 71 | 75 | $51,843 | $4,915 | 9.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 38 | 38 | $33,272 | $4,114 | 12.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 21 | 21 | $15,836 | $4,008 | 25.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 48 | 50 | $7,400 | $2,920 | 39.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 41 | 41 | $8,979 | $2,559 | 28.5% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 18 | 18 | $12,375 | $1,997 | 16.1% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2022 | 24 | 24 | $9,120 | $1,917 | 21.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 13 | 13 | $10,153 | $1,353 | 13.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 14 | $3,625 | $1,158 | 31.9% |
About Dr. David Silvers, MD
Dr. David Silvers, MD is a Gastroenterology healthcare provider based in Metairie, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316052087.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Silvers, MD has received a total of $138,069 in payments from pharmaceutical and medical device companies, with $6,113 received in 2024. These payments were reported across 1,143 transactions from 46 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($81,475).
As a Medicare-enrolled provider, Silvers has provided services to 2,239 Medicare beneficiaries, totaling 2,665 services with total Medicare billing of $229,814. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Metairie, LA
- Active Since 08/20/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1316052087
Products in Payments
- XIFAXAN (Drug) $24,164
- SKYRIZI (Biological) $21,635
- RINVOQ (Biological) $21,118
- HUMIRA (Biological) $14,091
- Humira (Biological) $13,116
- LINZESS (Drug) $7,148
- Trulance (Drug) $4,167
- UCERIS (Drug) $2,164
- STELARA (Biological) $1,332
- ZEPOSIA (Drug) $866.94
- TRULANCE (Drug) $758.97
- XELJANZ (Drug) $682.73
- Alinia Tablets 500mg 30 count bottle (Drug) $645.52
- ENTYVIO (Biological) $593.99
- Entyvio (Biological) $549.61
- RELISTOR (Drug) $373.93
- Donnatal (Drug) $289.40
- VIBERZI (Drug) $263.33
- Creon (Drug) $250.87
- Cimzia (Drug) $226.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Metairie
Dr. George Catinis, M.d, M.D
Gastroenterology — Payments: $269,321
Gastroenterology $269,321
Dr. Nicholas Persich, Md, MD
Gastroenterology — Payments: $47,190
Gastroenterology $47,190
Dr. Howard Brenner, M.d, M.D
Gastroenterology — Payments: $19,201
Gastroenterology $19,201
Dr. Vernon Carriere, Md, MD
Gastroenterology — Payments: $14,819
Gastroenterology $14,819
Dr. Mark Wegmann, M.d, M.D
Gastroenterology — Payments: $13,255
Gastroenterology $13,255
Mark Marino, Md, MD
Gastroenterology — Payments: $12,354
Gastroenterology $12,354